July 15, 2019
|
July 17, 2019
|
July 17, 2019
|
July 3, 2019
|
December 31, 2019 (Final data collection date for primary outcome measure)
|
nocturnal symptoms in patients with Parkinson's disease [ Time Frame: January 31, 2020 ] the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease
|
Same as current
|
No Changes Posted
|
Not Provided
|
Not Provided
|
Not Provided
|
Not Provided
|
|
Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
|
Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
|
This is a cross-sectional, retrospective clinical observation study focusing on the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease.
|
This study was a cross-sectional, retrospective clinical observation study investigating the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease through the Parkinson's disease sleep-related scale. At the same time, the effects of nocturnal symptoms on the quality of life of patients with Parkinson's disease were studied. About 1,500 Parkinson's patients will be recruited into the study who come from Shanghai, China.
|
Observational
|
Observational Model: Case-Only Time Perspective: Cross-Sectional
|
Not Provided
|
Not Provided
|
Probability Sample
|
Parkinson's disease patients diagnosed according to the diagnostic criteria of MDS
|
Parkinson's Disease
|
Other: Nocturnal symptoms
Parkinson's disease patients with or without nocturnal symptoms
|
Parkinson's disease patients
Parkinson's disease patients with or without nocturnal symptoms
Intervention: Other: Nocturnal symptoms
|
Grandas F, Iranzo A. Nocturnal problems occurring in Parkinson's disease. Neurology. 2004 Oct 26;63(8 Suppl 3):S8-11. Review.
|
|
Recruiting
|
1500
|
Same as current
|
January 31, 2020
|
December 31, 2019 (Final data collection date for primary outcome measure)
|
Inclusion Criteria:
- Parkinson's disease patients diagnosed according to the diagnostic criteria of MDS
- Signing informed consent
Exclusion Criteria:
- clinically suspected Parkinson's disease, has not been diagnosed;
- suspected or diagnosed as secondary Parkinson's syndrome (vascular, drug, traumatic, encephalitis, toxic, etc.);
- suspected or diagnosed as atypical Parkinson's syndrome (progressive supranuclear palsy, multiple system atrophy, cortical basal ganglia degeneration, etc.);
- There is a clear history of stroke, moderate to severe traumatic brain injury, hydrocephalus, brain surgery or history of brain tumors;
- severe cognitive impairment or psychiatric symptoms;
- Can not cooperate with the completion of the study.
|
Sexes Eligible for Study: |
All |
|
Child, Adult, Older Adult
|
No
|
Contact: Yu Zhang |
8613916006909 |
zhangyu0330@126.com |
|
|
China
|
|
|
NCT04023201
|
XHEC-C-2019-094
|
No
|
Studies a U.S. FDA-regulated Drug Product: |
No |
Studies a U.S. FDA-regulated Device Product: |
No |
|
Plan to Share IPD: |
Undecided |
|
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
|
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
|
Not Provided
|
Study Chair: |
Zhenguo Liu, Doctor |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
|
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
|
July 2019
|